Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma Bladder

Explore clinical trials studying Urothelial Carcinoma Bladder. Study availability and eligibility vary by location and protocol.

33 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma Bladder trial results

Recruiting

Renal Retention in High Grade Upper Tract Urothelial Cancer

NCT05656235

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Johns Hopkins University: Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Enrolling by Invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT07218003

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Not Yet Recruiting

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

NCT07725796

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +20 more
Locations
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Michael G Oefelein Clinical Trials Bakersfield, California, United States
  • Urology Center of Southern California Murrieta, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions